NX One MAX

About Nodexus

Nodexus is a private, early-revenue stage company founded in 2018 that has developed the NX One, a low-cost, benchtop microfluidic cell sorter. Its technology differentiates itself through ultra-gentle processing for high cell viability, a contamination-free disposable cartridge workflow, and a significantly lower price point than traditional fluorescence-activated cell sorting (FACS) systems. The company serves the research tools and diagnostics sectors, enabling applications from single-cell genomics and CRISPR workflows to organoid sorting and antibody development. Nodexus is positioned to democratize access to cell sorting technology for academic and biopharma labs with budget constraints.